Belmont, CA, United States of America

John Thipphawong


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by John Thipphawong in Erectile Dysfunction Treatment

Introduction

John Thipphawong is an accomplished inventor based in Belmont, California. He has made significant contributions to the field of medicine, particularly in the treatment of erectile dysfunction. His innovative approach combines the use of testosterone and fast-acting drugs to enhance libido and address erectile dysfunction effectively.

Latest Patents

Thipphawong holds a patent for "Methods and compositions for treating erectile dysfunction." This patent outlines methods for increasing libido and treating erectile dysfunction in men. The methods involve administering a formulation of testosterone, a fast-acting drug, or a combination of both, with at least one component delivered through aerosolization. The formulation is designed to be aerosolized and inhaled, allowing the active ingredients to deposit on lung tissue and enter the circulatory system efficiently.

Career Highlights

Thipphawong is associated with Aradigm Corporation, where he has been instrumental in developing innovative treatments. His work focuses on improving patient outcomes through advanced therapeutic methods. His dedication to research and development has positioned him as a key figure in the medical community.

Collaborations

Thipphawong has collaborated with notable colleagues, including Reid M Rubsamen and Robert B Cole. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

John Thipphawong's contributions to the treatment of erectile dysfunction highlight his commitment to advancing medical science. His innovative methods and formulations represent a significant step forward in addressing this common issue.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…